Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(450/week)
Manufacturing
(348/week)
Technology
(352/week)
Energy
(230/week)
Other Manufacturing
(292/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Psoriatic arthritis
Oct 11, 2018
Janssen To Highlight Data From Broad Rheumatology Portfolio At The 2018 Annual Meeting Of The American College Of Rheumatology
Oct 09, 2018
Health Canada Approves New Indications for XELJANZ(TM) in Ulcerative Colitis (UC) & Psoriatic Arthritis (PsA)
Oct 08, 2018
More Rheumatologists are Using Pfizer's Xeljanz in Psoriatic Arthritis Patients, Outpacing the Impressive Growth Displayed by Eli Lilly's Taltz in the Previous Quarter
Oct 08, 2018
AbbVie to Present New Data for Upadacitinib and HUMIRA® (adalimumab) at the 2018 ACR/ARHP Annual Meeting
Sep 10, 2018
Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz® and Tremfya® in Patients with Moderate-to-Severe Plaque Psoriasis
Aug 22, 2018
Nuevolution Discloses the Identity of its "Cytokine X" Program being Interleukin IL-17A and Initiates Promotion of its Small Molecule IL-17A Inhibitor Program Targeting Inflammatory Diseases
Aug 13, 2018
Escalier Doses First Patient with ESR-114 and Announces Clinical Advisory Board
Jul 24, 2018
Unlike Beauty, Psoriasis More Than Skin Deep
Jul 17, 2018
Rheumatologist User Base for Eli Lilly's Taltz in Psoriatic Arthritis (PsA) Boasts Strong Growth in Q2, While Use of Pfizer's Xeljanz Has Remained Flat Over the Past Quarter
Jun 20, 2018
Health Canada Approves Taltz® (ixekizumab) for Treatment of Active Psoriatic Arthritis
Jun 19, 2018
Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis
Jun 12, 2018
AbbVie Presents Additional Outcomes Data from Three Upadacitinib Phase 3 Studies in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR 2018)
Jun 11, 2018
Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology
Jun 11, 2018
Janssen to Showcase New Data Across Broad Rheumatology Portfolio and Immunology Pipeline at EULAR 2018
Jun 05, 2018
More than 5,000 Patients Enrolled in Corrona® Psoriasis Registry
Jun 05, 2018
Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis
May 30, 2018
TNF Cycling in Psoriatic Arthritis Declines for the Second Year in a Row as Newly Approved Agents Such as Pfizer's Xeljanz and Eli Lilly's Taltz Claim Their Share of the Switching Population
May 22, 2018
Lilly's Taltz® (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area
May 15, 2018
Psoriatic Arthritis Awareness Project Films Premiere during PsA Action Month
Apr 25, 2018
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study in Japanese Patients
‹‹
Page 4
››
Latest News
Mar 29, 2024
Dubai Electricity and Water Authority PJSC Shareholders Approve Payment of AED 3.1 Billion in Dividends
Mar 29, 2024
Prevalon Energy Secures Contract with Idaho Power for New Integrated Battery Energy Storage System (BESS)
Mar 29, 2024
Element Solutions Inc to Participate in an Electronics Q&A Session Hosted by Goldman Sachs
Mar 29, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend U. S. Steel Shareholders Vote “FOR”...
Mar 29, 2024
Elevate Your Sales Skills with BRS Roofing Supply's Exclusive Bootcamp Featuring Expert Taylor McCarthy
Mar 29, 2024
AC Direct Announces NASCAR Sponsorship of Greg Van Alst
Mar 29, 2024
The Next Chapter for Bell’s H-1 Helicopters Begins
Mar 29, 2024
The Next Chapter for Bell’s H-1 Helicopters Begins
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events